Home
Conditions
Lymphoma

Clinical trial condition

Lymphoma

Explore clinical trials studying Lymphoma. Study availability and eligibility vary by location and protocol.

2,141 public trials 305 recruiting studies

Refine in advanced search Browse all conditions

Lymphoma trial results

Completed

Application of Telemedicine to the Management of Aggressive Lymphomas

NCT03336138

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +5 more
Locations: University Hospital of Toulouse Toulouse, France

Clinique Claude Bernard Albi, France

Hospital Auch, France

Bayonne Hospital Bayonne, France

View Trial Details

Completed

Adaptive Bridging RT in R/R B-cell Lymphoma (Pre-CAR T)

NCT06004167

Conditions: Diffuse Large B Cell Lymphoma, Disease Attributes, Follicular Lymphoma, +21 more
Locations: Massachusetts General Hospital Boston, Massachusetts, United States

Dana-Farber Cancer Institute Boston, Massachusetts, United States

View Trial Details

Completed

Low-dose Chidamide Maintenance Therapy After Allo-HSCT for T-cell Acute Lymphoblastic Leukemia or T-cell Lymphomas

NCT05991973

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +6 more
Locations: The First Hospital of Zhejiang Medical Colleage Zhejiang University Hangzhou, Zhejiang, China

View Trial Details

Completed

A Phase II Study of Single Agent Brentuximab Vedotin in Relapsed/Refractory CD30 Low (<10%) Mature T Cell Lymphoma (TCL)

NCT02588651

Conditions: Adult T-Cell Leukemia/Lymphoma, Angioimmunoblastic T-cell Lymphoma, Enteropathy Associated T-cell Lymphoma, +22 more
Locations: Wayne State University, Karmanos Cancer Institute Detroit, Michigan, United States

Hackensack University Medical Center Hackensack, New Jersey, United States

University Hospitals Cleveland Medical Center, Case Comprehensive Cancer Center Cleveland, Ohio, United States

Cleveland Clinic Taussig Cancer institute, Case Comprehensive Cancer Center Cleveland, Ohio, United States

View Trial Details

Completed

A Study Evaluating the Safety of Cal-1 (LVsh5/C46) Drug Product in HIV-1 Infected Patient With High Risk Lymphoma

NCT03593187

Conditions: HIV-1 Infection, Hemic and Lymphatic Diseases, Immune System Diseases, +6 more
Locations: Hôpital Saint Louis Paris, France

View Trial Details

Completed

Study Investigating the Cardiotoxicity of Anthracyclines in Patients With Diffuse Large B-Cell

NCT02916316

Conditions: Cardiotoxicity, Cardiovascular Diseases, Chemically-Induced Disorders, +16 more
Locations: AO Riuniti Papardo Piemonte Messina, ME, Italy

ASST Grande Ospedale Metropolitano Niguarda Milan, MI, Italy

Istituto Clinico Humanitas Rozzano, MI, Italy

Nuovo Ospedale Di Sassuolo S.P.A. Sassuolo, Modena, Italy

View all 18 locations

View Trial Details

Completed

Haploidentical BMT With Post-Transplant Cyclophosphamide and Bendamustine

NCT02996773

Conditions: Actinomycetales Infections, Acute Lymphoblastic Leukemia, Acute Myelogenous Leukemia, +52 more
Locations: The University of Arizona Cancer Center Tucson, Arizona, United States

View Trial Details

Completed

Study of Ulevostinag (MK-1454) Alone or in Combination With Pembrolizumab (MK-3475) in Participants With Advanced/Metastatic Solid Tumors or Lymphomas (MK-1454-001)

NCT03010176

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +7 more
Locations: University of Alabama ( Site 0009) Birmingham, Alabama, United States

University of California San Francisco ( Site 0007) San Francisco, California, United States

UCSF ( Site 0015) San Francisco, California, United States

UCLA Medical Center ( Site 0005) Santa Monica, California, United States

View all 19 locations

View Trial Details

Completed

Resiliency in Older Adults Undergoing Bone Marrow Transplant

NCT04188678

Conditions: Acute Myelogenous Leukemia, Blood Cancer, Bone Marrow Diseases, +18 more
Locations: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Baltimore, Maryland, United States

View Trial Details

Completed

CBT-I in Primary Brain Tumor Patients: Phase IIc Randomized Feasibility Pilot Trial

NCT06439420

Conditions: Astrocytoma, Brain Diseases, Brain Neoplasms, +31 more
Locations: Virginia Commonwealth University Richmond, Virginia, United States

View Trial Details

Lymphoma

Lymphoma trial results

Related conditions